Clotrimazole and Betamethasone Dipropionate
- Product NDC
- 53002-9740
- 11-digit product format
- 530029740
- Labeler code
- 53002
- Product ID
- 53002-9740_e98def49-c684-4258-8593-d86a2d46c020
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clotrimazole and Betamethasone Dipropionate
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA202894
- Marketing category
- ANDA
- Marketing start
- 2015-11-06
- Marketing end
- 0000-00-00
- Substance
- BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
- Active strength
- 1 mg/g; mg/g
- Pharmacologic classes
- Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 53002-9740 | I | Inactivated by FDA | 2026-10-05 | ||
| excluded package | package | 53002-9740 | 53002-9740-1 | I | Inactivated by FDA | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 53002-9740-1 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53002-9740-1 | E | Excluded after deficient or non-compliant submission was not corrected | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | Y | Unknown FDA exclusion code: Y | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53002-9740-1 | Y | Unknown FDA exclusion code: Y | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | Y | Unknown FDA exclusion code: Y | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53002-9740-1 | Y | Unknown FDA exclusion code: Y | 9bebd1f3094a… | 5416666fcb17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE | EQ 0.05% BASE;1% | CREAM / TOPICAL | 2015-10-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | 2015-10-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | 2015-10-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | 2015-10-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | 2015-10-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A202894-001 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | CREAM / TOPICAL | AB | 2015-10-30 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-08-23 18:47 UTC | 2025-08 | A202894-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202894-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202894-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202894-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202894-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202894-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202894-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A202894-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202894-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202894-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202894-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A202894-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202894-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A202894-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A202894-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A202894-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A202894-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A202894-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202894-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A202894-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A202894-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A202894-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A202894-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202894-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202894-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202894-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A202894-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A202894-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202894-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202894-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202894-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202894-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A202894-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A202894-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202894-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A202894-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A202894-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202894-001 | AB | 1 | cb3db0bc1861… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b64d2752-34ef-378a-1f4f-8bff32b0d1ae | Product name | 4 | 20250626 |
| dde7b902-54a1-627e-12f1-9e6d244ab88c | Product name | 4 | 20250317 |
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 69b49899-11cf-4f7e-bd0a-7dc93b27311b | Product name | 3 | 20250130 |
| cb7783e0-feaa-7e56-fb3b-d43b6efa77c9 | Product name | 2 | 20250121 |
| bbdc14c7-d940-43b5-a2f7-36c425991f3c | Product name | 1 | 20240320 |
| 0a2fcc35-464b-9ec2-a622-753662cdd48c | Product name | 3 | 20240216 |
| 6f762601-17ef-4321-8f47-77783d3c4d8b | Product name | 3 | 20231116 |
| 1dbefad7-ab34-69c3-e51a-e7148aa38f70 | Product name | 5 | 20220921 |
| 7fea2046-07a9-4bb6-9409-828ac6f1f6df | Product name | 1 | 20210201 |
| f059f1a2-0e64-4839-9a7f-42687c91a44b | Product name | 1 | 20201007 |
| 4ea9e4b5-b452-48ad-9b25-b9a4d403405d | Product name | 1 | 20160310 |
| f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6 | Product name | 2 | 20151106 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
| 4f07db9b-3707-3e2c-05b5-d7852ba808c4 | Product name | 1 | 20140508 |
| f5395dd2-4395-d8c6-3477-8c2d4a2f951c | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53002-9740-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-f2fe-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM safely and effectively. See full prescribing information for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM. CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE Cream, USP, for topical use Initial U.S. Approval: 1984 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53002-9740-1 | Clotrimazole and Betamethasone Dipropionate | 15 g in 1 TUBE | CREAM | 15 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53002-9740 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM [RPK PHARMACEUTICALS, INC.] | 6 | Legacy NDC, 1 package rows | 20220129_756180ee-4df5-4c02-8657-8d9882991036.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Direct Rx | bbf26437-c9b4-d8e6-e053-2a95a90a0062 | 2025-01-17 | Warnings, Adverse reactions | 202894 ANDA202894 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 5cc511e4-3e7d-70d6-e053-2a91aa0a8044 | 2024-06-04 | Warnings, Adverse reactions | 202894 ANDA202894 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Proficient Rx LP | c6e4bf5f-f6d6-489e-9286-c30568c601b7 | 2021-01-01 | Warnings, Adverse reactions | 202894 ANDA202894 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Glenmark Pharmaceuticals Inc. USA | 8dcd24cb-e568-428a-88ac-737d115cc54d | 2020-11-09 | Warnings, Adverse reactions | 202894 ANDA202894 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 53002-9740-1 | 53002974001 | 15 g in 1 TUBE (53002-9740-1) | 15 g | 2018-10-01 | 0000-00-00 | No | No | Current |